LianBio (LIANY) Earnings Date & Reports

LianBio is a science-driven biopharmaceutical company dedicated to developing and commercializingÂ medicines for patients with unmet medical needs, with an initial focus on in-licensing assets for Greater China and other Asian markets... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

LIANY is expected to report earnings to fall 13.64% to -18 cents per share on March 26

Q4'23

Est.

$-0.19

Q3'23

Beat

by $0.11

Q2'23

Beat

by $0.09

Q1'23

Beat

by $0.07

Q4'22

Beat

by $0.10

The last earnings report on November 13 showed earnings per share of -21 cents, beating the estimate of -33 cents. With 600.00 shares outstanding, the current market capitalization sits at 21.61M.

View a ticker or compare two or three

Compare

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

103 Carnegie Center Drive

Phone

+1 609 486-2308

Employees

Web

https://www.lianbio.com